New packaging helps life sciences meet complex cold chain demands
Big Pharma is getting even bigger, and cold chain support, including packaging, is all the more critical as the industry grows from an estimated global worth of $300 billion currently to $400 billion by 2020, according to the World Health Organization.
In the life sciences field, temperature-controlled biologics and biosimilars, which are genetically based drugs as opposed to chemical-based, are responsible for powering much of that growth.
Another trend related to the guidelines for the storage of pharmaceuticals — and one that’s getting a lot of attention — is controlled room temperature, Lawler said. It’s becoming further defined with real temperature minimums and maximums, such as the most common 15 to 25 degrees Celsius range. Organizations throughout the cold chain are also increasingly expected to support CRT.